Platinum derivatives and cancer treatments
CA 1319681 C · Owner: Efamol Limited · Inventors: Davidson, Bruce Clement
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Derivatives of platinum group metals particulary, platinum itself, wherein the metal is linked to one or more pharmaceutically acceptable steroid fatty acid or, other lipophilic residues aiding transport of the metal across cell membranes in the body, particularly fatty acid amine or fatty acid amide groups RCH2NH- or where R is a hydrocarbon group, suitably or 10 to 30 carbon atoms. The derivatives are useful in the treatment of cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted June 29, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended June 29, 2010.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.